In8bio
Price & Volume
Stats
See moreOpen | $1.77 |
Previous Close | $1.78 |
Day Range | $1.76-$1.77 |
52W Range | $1.53-$12.54 |
Market Cap | $8.2M |
Shares Short | 37,166 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.26 |
News
See moreYahoo Finance • last month
IN8bio GAAP EPS of -$0.85 beats by $0.40
Yahoo Finance • last month
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
Yahoo Finance • 4 months ago
IN8bio GAAP EPS of -$1.24 beats by $0.56
Yahoo Finance • 6 months ago
IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
About
CEO | Mr. Tai-Wei Ho |
CFO | Mr. Patrick McCall CPA |
Address | 350 5th Avenue, New York, NY, United States, 10118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |
